Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Beyond the habitable zone: Exoplanet atmospheres are the next clue to finding life on planets orbiting distant stars - 2How Skoda Lost Its Biggest Market In Just Seven Years
- 3How 2025 became the year of comet: The rise of interstellar 3I/ATLAS, an icy Lemmon and a cosmic SWAN
- 4Figure out How to Plan for Your Web-based Degree monetarily
- 56 Objections for an Ocean side Wedding
- The 15 Most Rousing TED Chats on Self-awareness
- Wolf Bites Woman in Shocking Attack at Busy Shopping Center
- Are multiverses real? An astrophysicist explains why it depends on how you define ‘real’
- Mom finds out she has cancer after noticing something was off while breastfeeding
- Colombia's military rescues 6 siblings who hid in the rainforest to escape from a rebel group
- Novartis to build manufacturing hub in North Carolina, creating 700 jobs
- 4 buzzy new TV shows to watch — plus the return of 'The Comeback,' 'Jury Duty' and more
- Israel reports second missile fire from Yemen since start of Iran war
- Pick Your Number one Sort Of Music
